In this installment, we delve into one of the most debated scientific advancements of our time: CRISPR gene-editing ...
New research adds to our understanding of the function of the human genome. An international team of researchers has made ...
A ruthenium catalyst facilitated the polymerization, or polymer addition. Industrial firms have used this catalyst to make ...
CRISPR Therapeutics AG (NASDAQ:CRSP), a leading biotechnology company specializing in gene-based medicines with a market capitalization of $3.45 billion, stands at a critical juncture as it navigates ...
This important study reveals a role for IκBα in the regulation of embryonic stem cell pluripotency. The solid data in mouse embryonic stem cells include separation of function mutations in IκBα to ...
Researchers at the Broad Institute of MIT and Harvard have developed a gene-editing treatment for prion disease that extends ...